+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Interferons Market 2025-2029 - Product Thumbnail Image

Interferons Market 2025-2029

  • Report
  • May 2025
  • 212 Pages
  • Global
From
From
Recombinant DNA Technology - Global Strategic Business Report - Product Thumbnail Image

Recombinant DNA Technology - Global Strategic Business Report

  • Report
  • August 2025
  • 212 Pages
  • Global
From
Hyper Personalized Medicines - Global Strategic Business Report - Product Thumbnail Image

Hyper Personalized Medicines - Global Strategic Business Report

  • Report
  • August 2025
  • 390 Pages
  • Global
From
Precision Medicine - Global Strategic Business Report - Product Thumbnail Image

Precision Medicine - Global Strategic Business Report

  • Report
  • August 2025
  • 279 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • August 2025
  • 196 Pages
  • Global
From
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 377 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • August 2025
  • 211 Pages
  • Global
From
Loading Indicator